|
Real-time Estimate
Cboe BZX
20:32:09 05/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 28.36 USD | -5.23% |
|
-4.92% | +4.64% |
| 09-22 | Top Midday Decliners | MT |
| 09-22 | Celldex Therapeutics, Inc. - Special Call |
| Market Cap | 2.35B 2.09B 1.92B 1.74B 3.29B 222B 3.38B 23.01B 9.2B 118B 8.82B 8.63B 371B | P/E 2026 * |
-7.13x | P/E 2027 * | -6.99x |
|---|---|---|---|---|---|
| Enterprise Value | 1.69B 1.5B 1.38B 1.25B 2.36B 160B 2.43B 16.53B 6.61B 84.48B 6.34B 6.2B 267B | EV / Sales 2026 * |
913x | EV / Sales 2027 * | 195x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLDX | Delayed | |
CBOE
| CLDX | Real-time | |
|
Tradegate
| TCE2 | Real-time | |
|
Börse Stuttgart
| TCE2 | Delayed | |
|
Deutsche Boerse AG
| TCE2 | Delayed | |
|
Berne S.E.
| TCE1 | End-of-day quote | |
|
Boerse Muenchen
| TCE2 | Real-time |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | -5.35% | ||
| 1 week | -4.92% | ||
| Current month | -5.58% | ||
| 1 month | -12.80% | ||
| 3 months | -30.78% | ||
| 6 months | -16.07% | ||
| Current year | +4.64% |
| 1 week | 28.34 |  | 30.92 |
| 1 month | 27.46 | | 32.68 |
| Current year | 22.33 | | 45.14 |
| 1 year | 22.1 | | 45.14 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 53.18 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 29/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 31/08/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 31/03/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 30/11/2008 |
Harry Penner
CHM | Chairman | 80 | 04/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 29/02/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Executive/Senior Manager | 20,000 | 0.0255% | ||
| 25/06/26 | Free | Director | 26,000 | 0.0331% | ||
| 25/06/26 | Free | Chief Technology Officer | 57,000 | 0.0726% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.15% | -4.92% | +19.76% | -3.17% | 2.35B | |
| +3.80% | +8.47% | +64.65% | +77.70% | 66.87B | |
| +1.63% | +4.93% | +24.89% | +102.90% | 56.55B | |
| +0.07% | +2.39% | +11.12% | +75.17% | 57.2B | |
| -0.04% | -4.04% | +25.62% | +33.04% | 43.47B | |
| -9.31% | -5.26% | +203.77% | +736.86% | 42.8B | |
| +2.42% | +4.86% | +21.22% | +98.63% | 42.95B | |
| +1.59% | -4.04% | +97.66% | +81.57% | 32.11B | |
| +7.50% | +13.28% | +28.05% | +64.46% | 34.01B | |
| -2.55% | -3.72% | -42.51% | +350.67% | 24.13B | |
| Average | -0.06% | +3.67% | +45.42% | +161.78% | 40.24B | |
| Weighted average by Cap. | +0.68% | +3.89% | +50.25% | +163.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85M 1.65M 1.51M 1.37M 2.59M 175M 2.66M 18.11M 7.24M 92.58M 6.94M 6.79M 292M | 8.76M 7.81M 7.14M 6.5M 12.26M 828M 12.59M 85.77M 34.3M 438M 32.88M 32.17M 1.38B |
| Net income | -319M -284M -260M -237M -447M -30.16B -459M -3.13B -1.25B -15.97B -1.2B -1.17B -50.41B | -361M -322M -294M -268M -505M -34.11B -519M -3.53B -1.41B -18.06B -1.35B -1.33B -57B |
| Net Debt | -662M -590M -540M -492M -927M -62.59B -952M -6.49B -2.59B -33.15B -2.49B -2.43B -105B | -639M -569M -521M -474M -894M -60.36B -918M -6.25B -2.5B -31.97B -2.4B -2.35B -101B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | US$28.42 | -5.05% | 542,998 |
| 04/11/26 | US$29.93 | +0.74% | 911,485 |
| 03/11/26 | US$29.71 | +2.31% | 872,044 |
| 02/11/26 | US$29.04 | -3.52% | 956,133 |
| 30/10/26 | US$30.10 | +0.70% | 870,776 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
